Submission Details
| 510(k) Number | K252749 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 29, 2025 |
| Decision Date | January 06, 2026 |
| Days to Decision | 130 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
K252749 is an FDA 510(k) clearance for the Medconn 8K Glycated Hemoglobin Test System, a Hemoglobin A1c Test System (Class II — Special Controls, product code PDJ), submitted by Shanghai Medconn Medical Technology Co., Ltd. (Shanghai, CN). The FDA issued a Cleared decision on January 6, 2026, 130 days after receiving the submission on August 29, 2025. This device falls under the Chemistry review panel. Regulated under 21 CFR 862.1373.
| 510(k) Number | K252749 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 29, 2025 |
| Decision Date | January 06, 2026 |
| Days to Decision | 130 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | PDJ — Hemoglobin A1c Test System |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.1373 |
| Definition | Quantitative Determination Of Hemoglobin A1c To Aid In The Diagnosis Of Diabetes. |